Infections are a common and serious complication of ventricular Background: shunts that can lead to significant mortality and morbidity. Treatment consists of surgical and antimicrobial therapy, but there is a lack of evidence regarding optimal management. We therefore aimed to analyse the current practice and patient outcomes within a large tertiary referral centre.We identified cases of infection in ventriculoperitoneal shunts from Methods: January 2000 until April 2015 in our institution. All patients were under 18 years at the time of infection. Clinical, microbiological and radiological data were collected with the use of a standardised proforma. Non-parametric tests were used for statistical analysis.There were 92 episodes of infection in 65 patients. The most common Results: microorganisms were coagulase-negative staphylococci (47%), followed by (16%). Surgical treatment included shunt Staphylococcus aureus externalisation (15%) and complete removal (67%). Antibiotics were given in 97% of the patients in addition to surgery. Vancomycin, linezolid, cefotaxime, meropenem and rifampicin were used most frequently. The median duration of antibiotic treatment was 18 days (IQR 14-25 days). Two patients died from consequences of a shunt infection and seven had recurrent infection.It would be beneficial to develop a guideline for recognition and Conclusions: treatment of shunt infections. Complete removal of the shunt and placement of an EVD seems the safest surgical treatment. Empirical antibiotic treatment should be started as soon as possible. A combination of linezolid and ceftriaxone would be appropriate first line antibiotics, with meropenem as second line. Antibiotics can be rationalised once the CSF culture results are known.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.